Jordan M. Cloyd
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jordan M. Cloyd has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Brendan Christopher Visser
Stanford University
4 shared publications Irene L Wapnir
Department of Surgery; Stanford University; Stanford CA
3 shared publicationsIrene L. Wapnir
Stanford University
3 shared publicationsTina Hernandez-Boussard
Stanford University
3 shared publicationsYifei Ma
Department of Surgery, Stanford University, Stanford, California
3 shared publications- George A. Poultsides
Department of Surgery, Stanford University, Stanford, CA, USA
2 shared publications
Latest Publications
- Open Access
- 1 September 2015
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 150 (9) , 849-856
Association Between Weekend Discharge and Hospital Readmission Rates Following Major Surgery
Hospital readmission, defined as admission to a hospital within 30 days of discharge from an acute care facility, is associated with increased morbidity, mortality, and health care expenditures.1 In 2013, as part of the Patient Protection and Affordable Care Act, Medicare began assigning financial penalties to those hospitals with the highest readmission rates for common medical conditions.2 In its third year, the program announced penalties for 2610 hospitals that will total more than $428 million.3 Beginning in 2015, the Centers for Medicare and Medicaid Services will expand to include penalties for unplanned readmissions after at least 1 surgical procedure.4 For these reasons, identifying risk factors that contribute to hospital readmissions for patients undergoing surgery have important quality and health policy implications.
- 1 September 2015
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 150 (9) , 849-856
Open AccessAssociation Between Weekend Discharge and Hospital Readmission Rates Following Major Surgery
Hospital readmission, defined as admission to a hospital within 30 days of discharge from an acute care facility, is associated with increased morbidity, mortality, and health care expenditures.1 In 2013, as part of the Patient Protection and Affordable Care Act, Medicare began assigning financial penalties to those hospitals with the highest readmission rates for common medical conditions.2 In its third year, the program announced penalties for 2610 hospitals that will total more than $428 million.3 Beginning in 2015, the Centers for Medicare and Medicaid Services will expand to include penalties for unplanned readmissions after at least 1 surgical procedure.4 For these reasons, identifying risk factors that contribute to hospital readmissions for patients undergoing surgery have important quality and health policy implications.
- 30 June 2015
- Published by Wiley in Journal of Hospital Medicine
- Vol. 10 (11) , 731-737
Is weekend discharge associated with hospital readmission?
BACKGROUND: Although recent evidence suggests worse outcomes for patients admitted to the hospital on a weekend, the impact of weekend discharge is less understood.METHODS: Utilizing the 2012 California Office of Statewide Health Planning and Development database, the impact of weekend discharge on 30‐day hospital readmission rates for patients admitted with acute myocardial infarction (AMI), congestive heart failure (CHF), or pneumonia (PNA) was investigated.RESULTS: Out of 266,519 patients, 60,097 (22.5%) were discharged on a weekend. Unadjusted 30‐day hospital readmission rates were similar between weekend and weekday discharges (AMI: 21.9% vs 21.9%; CHF: 15.4% vs 16.0%; PNA: 12.1% vs 12.4%). Patients discharged on a weekday had a longer length of stay and were more often discharged to a skilled nursing facility. However, in multivariable logistic regression models, weekend discharge was not associated with readmission (AMI: odds ratio [OR] 1.02 [95% CI: 0.98‐1.06]; CHF: OR 0.99 [95% CI: 0.94‐1.03]; PNA: OR 1.02 (95% CI: 0.98‐1.07)).CONCLUSIONS: Among patients in California with AMI, CHF, and PNA, discharge on a weekend was not associated with an increased hospital readmission rate. Journal of Hospital Medicine 2015;10:731–737. © 2015 Society of Hospital Medicine
- 30 June 2015
- Published by Wiley in Journal of Hospital Medicine
- Vol. 10 (11) , 731-737
Is weekend discharge associated with hospital readmission?
BACKGROUND: Although recent evidence suggests worse outcomes for patients admitted to the hospital on a weekend, the impact of weekend discharge is less understood.METHODS: Utilizing the 2012 California Office of Statewide Health Planning and Development database, the impact of weekend discharge on 30‐day hospital readmission rates for patients admitted with acute myocardial infarction (AMI), congestive heart failure (CHF), or pneumonia (PNA) was investigated.RESULTS: Out of 266,519 patients, 60,097 (22.5%) were discharged on a weekend. Unadjusted 30‐day hospital readmission rates were similar between weekend and weekday discharges (AMI: 21.9% vs 21.9%; CHF: 15.4% vs 16.0%; PNA: 12.1% vs 12.4%). Patients discharged on a weekday had a longer length of stay and were more often discharged to a skilled nursing facility. However, in multivariable logistic regression models, weekend discharge was not associated with readmission (AMI: odds ratio [OR] 1.02 [95% CI: 0.98‐1.06]; CHF: OR 0.99 [95% CI: 0.94‐1.03]; PNA: OR 1.02 (95% CI: 0.98‐1.07)).CONCLUSIONS: Among patients in California with AMI, CHF, and PNA, discharge on a weekend was not associated with an increased hospital readmission rate. Journal of Hospital Medicine 2015;10:731–737. © 2015 Society of Hospital Medicine
- 16 November 2014
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 148 (3) , 637-644
Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast
Although rare, neuroendocrine carcinoma of the breast (NECB) is becoming an increasingly recognized entity. The current literature is limited to case reports and small series and therefore a comprehensive population-based analysis was conducted to investigate the clinicopathologic features and long-term outcomes associated with NECB. We included all patients in the SEER Database from 2003 to 2010 with a diagnosis of NECB. The 2012 WHO classification system was used to categorize patients based on histopathologic diagnosis: well-differentiated neuroendocrine tumors, small/oat cell or poorly differentiated neuroendocrine tumors, adenocarcinoma with neuroendocrine features (ANF), large cell neuroendocrine and carcinoid tumors. Survival analysis was performed for disease specific (DSS) and overall (OS) survival. Of the 284 cases identified, 52.1 % were classified as well-differentiated, 25.7 % small cell, 14.8 % ANF, 4.9 % large cell, and 2.5 % carcinoid. In general, patients presented with advanced disease: 36.2 % had positive lymph node metastases and 20.4 % presented with systemic metastases. Five-year DSS rates for stage I–IV NECB were 88.1, 67.8, 60.5, and 12.4 %, respectively, while five-year OS rates were 77.9, 57.3, 52.9, and 8.9 %, respectively. DSS and OS were significantly different for well-differentiated neuroendocrine tumors and ANFs compared to small cell and carcinoid tumors. On univariate Cox proportional hazards regression, small cell carcinoma was significantly associated with worse DSS (OR 1.97, 95 % CI 1.05–3.67) and OS (OR 2.66, 95 % CI 1.49–4.72) compared to other neuroendocrine tumors. NECB is associated with advanced stage disease at presentation and an unfavorable prognosis for stage II–IV disease and small cell, large cell, and carcinoid histologic subtypes.
- 16 November 2014
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 148 (3) , 637-644
Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast
Although rare, neuroendocrine carcinoma of the breast (NECB) is becoming an increasingly recognized entity. The current literature is limited to case reports and small series and therefore a comprehensive population-based analysis was conducted to investigate the clinicopathologic features and long-term outcomes associated with NECB. We included all patients in the SEER Database from 2003 to 2010 with a diagnosis of NECB. The 2012 WHO classification system was used to categorize patients based on histopathologic diagnosis: well-differentiated neuroendocrine tumors, small/oat cell or poorly differentiated neuroendocrine tumors, adenocarcinoma with neuroendocrine features (ANF), large cell neuroendocrine and carcinoid tumors. Survival analysis was performed for disease specific (DSS) and overall (OS) survival. Of the 284 cases identified, 52.1 % were classified as well-differentiated, 25.7 % small cell, 14.8 % ANF, 4.9 % large cell, and 2.5 % carcinoid. In general, patients presented with advanced disease: 36.2 % had positive lymph node metastases and 20.4 % presented with systemic metastases. Five-year DSS rates for stage I–IV NECB were 88.1, 67.8, 60.5, and 12.4 %, respectively, while five-year OS rates were 77.9, 57.3, 52.9, and 8.9 %, respectively. DSS and OS were significantly different for well-differentiated neuroendocrine tumors and ANFs compared to small cell and carcinoid tumors. On univariate Cox proportional hazards regression, small cell carcinoma was significantly associated with worse DSS (OR 1.97, 95 % CI 1.05–3.67) and OS (OR 2.66, 95 % CI 1.49–4.72) compared to other neuroendocrine tumors. NECB is associated with advanced stage disease at presentation and an unfavorable prognosis for stage II–IV disease and small cell, large cell, and carcinoid histologic subtypes.
- 1 November 2014
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 18 (11) , 2034-2037
Early Vein Reconstruction and Right-to-Left Dissection for Left-Sided Pancreatic Tumors with Portal Vein Occlusion
- 1 November 2014
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 18 (11) , 2034-2037
Early Vein Reconstruction and Right-to-Left Dissection for Left-Sided Pancreatic Tumors with Portal Vein Occlusion
- 27 August 2014
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (2) , 573-580
Does the Extent of Resection Impact Survival for Duodenal Adenocarcinoma? Analysis of 1,611 Cases
Background Because duodenal adenocarcinoma (DA) is relatively rare, few studies have investigated the impact of resection type on long-term outcomes.
- 27 August 2014
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (2) , 573-580
Does the Extent of Resection Impact Survival for Duodenal Adenocarcinoma? Analysis of 1,611 Cases
Background Because duodenal adenocarcinoma (DA) is relatively rare, few studies have investigated the impact of resection type on long-term outcomes.
- 13 August 2014
- Published by Wiley in Journal of Surgical Oncology
- Vol. 110 (7) , 888-892
Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma
Background and Objectives Sentinel lymph node (SLN) biopsy has become the standard method of determining regional lymph node involvement in cutaneous melanoma. Although traditionally performed via injection of radioisotope tracers and blue dyes, fluorescent lymphangiography with indocyanine green (ICG) is an attractive alternative. Methods Fifty two consecutive patients with cutaneous melanoma of the trunk or extremities underwent SLNB. Preoperative lymphoscintigraphy was performed with technetium-99m sulfur colloid (TSC). Peritumoral intradermal injection of isosulfan blue (ISB) and ICG was then performed. Successful identification of a sentinel lymph node via each modality was then assessed. Results A total of 77 lymph nodes were identified from the 52 patients (range 1–3). The majority of melanomas were extremity-based, superficial spreading type, and had SLN localized to the axilla. There were no complications related to IcG administration. Rates of SLN detection were 96.2% for TSC, 59.6% for ISB, and 88.5% for IcG (P < 0.05 for ICG vs ISB). On univariate logistic regression analysis, no factors were found to be associated with failure of ICG. Conclusions Fluorescent lymphangiography using ICG is an effective method of SLN identification in patients with cutaneous melanoma of the trunk and extremities. When ICG and TSC are used in combination, ISB offers no additional advantage and may be safely omitted. J. Surg. Oncol. 2014 110:888–892.
- 13 August 2014
- Published by Wiley in Journal of Surgical Oncology
- Vol. 110 (7) , 888-892
Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma
Background and Objectives Sentinel lymph node (SLN) biopsy has become the standard method of determining regional lymph node involvement in cutaneous melanoma. Although traditionally performed via injection of radioisotope tracers and blue dyes, fluorescent lymphangiography with indocyanine green (ICG) is an attractive alternative. Methods Fifty two consecutive patients with cutaneous melanoma of the trunk or extremities underwent SLNB. Preoperative lymphoscintigraphy was performed with technetium-99m sulfur colloid (TSC). Peritumoral intradermal injection of isosulfan blue (ISB) and ICG was then performed. Successful identification of a sentinel lymph node via each modality was then assessed. Results A total of 77 lymph nodes were identified from the 52 patients (range 1–3). The majority of melanomas were extremity-based, superficial spreading type, and had SLN localized to the axilla. There were no complications related to IcG administration. Rates of SLN detection were 96.2% for TSC, 59.6% for ISB, and 88.5% for IcG (P < 0.05 for ICG vs ISB). On univariate logistic regression analysis, no factors were found to be associated with failure of ICG. Conclusions Fluorescent lymphangiography using ICG is an effective method of SLN identification in patients with cutaneous melanoma of the trunk and extremities. When ICG and TSC are used in combination, ISB offers no additional advantage and may be safely omitted. J. Surg. Oncol. 2014 110:888–892.
- 20 June 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (1) , 32-34
Acute Gastric Dilation and Necrosis as a Late Complication Following Laparoscopic Nissen Fundoplication
- 20 June 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (1) , 32-34
Acute Gastric Dilation and Necrosis as a Late Complication Following Laparoscopic Nissen Fundoplication
- 7 June 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 59 (12) , 2905-2908
Gastrointestinal Mucormycosis Initially Manifest as Hematochezia from Arterio-Enteric Fistula
- 7 June 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 59 (12) , 2905-2908
Gastrointestinal Mucormycosis Initially Manifest as Hematochezia from Arterio-Enteric Fistula
- 1 March 2014
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 18 (3) , 605-612
Does Chronic Kidney Disease Affect Outcomes after Major Abdominal Surgery? Results from the National Surgical Quality Improvement Program
- 1 March 2014
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 18 (3) , 605-612
Does Chronic Kidney Disease Affect Outcomes after Major Abdominal Surgery? Results from the National Surgical Quality Improvement Program
- 1 January 2014
- Published by Touch Medical Media, Ltd. in Oncology & Hematology Review
- Vol. 10 (01)
Radiation Therapy in Male Breast Cancer
Male breast cancer (MBC) is a relatively rare disease and because the dedicated literature on MBC is limited, management typically follows guidelines established for female breast cancer (FBC). Although radiation therapy (RT) constitutes a critical role in the treatment of MBC, several unique challenges influence its use. Most men with breast cancer present at an older age with more extensive and advanced stage disease than women. In contrast to the predominance of breast conservation therapy in women with breast cancer, the majority of men are treated with mastectomy, with or without post-mastectomy radiation. Although no prospective or randomized trials are available, retrospective data suggests that surgery followed by adjuvant RT significantly improves locoregional control (LRC) in men. This article reviews the utilisation, efficacy, and complications associated with adjuvant RT in MBC.
- 1 January 2014
- Published by Touch Medical Media, Ltd. in Oncology & Hematology Review
- Vol. 10 (01)
Radiation Therapy in Male Breast Cancer
Male breast cancer (MBC) is a relatively rare disease and because the dedicated literature on MBC is limited, management typically follows guidelines established for female breast cancer (FBC). Although radiation therapy (RT) constitutes a critical role in the treatment of MBC, several unique challenges influence its use. Most men with breast cancer present at an older age with more extensive and advanced stage disease than women. In contrast to the predominance of breast conservation therapy in women with breast cancer, the majority of men are treated with mastectomy, with or without post-mastectomy radiation. Although no prospective or randomized trials are available, retrospective data suggests that surgery followed by adjuvant RT significantly improves locoregional control (LRC) in men. This article reviews the utilisation, efficacy, and complications associated with adjuvant RT in MBC.